Sort

Search

01/07/2024 Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study
Manzanares, RG, Gamez, MA, Garcia, JM, Orna, JAG, Perez, AP, Barrios, V, Padial, LR, Sanchez, MMPA. Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Hualpa, JCP, García-Centeno, R, González-Fernández, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jiménez, C, Galiana, PA, Venegas, E, González-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Córdova, JM, Avilés-Pérez, MD, Asensio-Wandosell, D, Sampedro-Núñez, M, Cámara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs. ENDOCRINE-RELATED CANCER. 2024; 31(7)DOI:10.1530/ERC-24-0043. PMID:38713182. IF:4.600(Q1/3D).
01/07/2024 Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Ruiz-Cobo, JC, Llaneras, J, Forns, X, Moya, AG, Amiel, IC, Arencibia, A, Diago, M, Garcia-Samaniego, J, Castellote, J, Llerena, S, Rodriguez-Seguel, E, Mateos, B, Rodriguez, M, Zabal, JMR, Fernandez, I, Calleja, JL, Morillas, RM, Montoliu, S, Andrade, RJ, Aranda, EB, Hernandez-Guerra, M, Mate, CJ, Gonzalez-Santiago, JM, de Cuenca, B, Bernal-Monterde, V, Delgado, M, Turnes, J, Lens, S, Buti, M. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(2)DOI:10.1111/apt.18020. PMID:38695095. IF:6.700(Q1/1D).
01/07/2024 Genetic Diversity of Trypanosoma cruzi in the United States of America: The Least Endemic Country for Chagas Disease
Llovera, A, Abras, A, Fernández-Arévalo, A, Ballart, C, Heras, S, Muñoz, C, Gallego, M. Genetic Diversity of Trypanosoma cruzi in the United States of America: The Least Endemic Country for Chagas Disease. Life-Basel. 2024; 14(7)DOI:10.3390/life14070901. PMID:39063654. IF:3.400(Q1/3D).